Skip to main content

Current clinical trials and surveys

Novel clinical research conducted by the Lambert Initiative’s clinical team and collaborators within Australia
Our clinical team, in collaboration with expert clinicians and researchers around Australia, are focused on developing clinical evidence for cannabinoid-based therapeutics and understanding Australian community use of medicinal cannabis in a range of disease areas.

Clinical Trials

The Effect of Cannabidiol (CBD) on Simulated Car Driving Performance: A Dose-Ranging Study of Healthy Volunteers.

While research has shown that cannabis, and its major intoxicating ingredient – THC, impair car driving performance, the influence of cannabidiol (CBD) (alone) has not been studied. Findings from several investigations suggest that, unlike THC, CBD is non-intoxicating and does not impair cognitive function. However, given the potential harms associated with road traffic accidents and the increasing use of CBD (among both clinical and non-clinical populations) research clarifying its effect on driving performance is warranted. This study will investigate the effect of acute, oral CBD treatment (at three different doses) on simulated driving performance using a crossover design. 

Study site: The Woolcock Institute of Medical Research, Camperdown NSW 2050

Status: Recruiting

Check your eligibility here 

The CANSLEEP Study

Exploring the effects of combined CBD and THC (20:1) on sleep and brain activation in patients with insomnia disorder. Eligible participants undergo two overnight sleep studies receiving randomised active and placebo treatments. This study is being led by Professor Ron Grunstein. See here for more information.

Study site: Woolcock Institute of Medical Research, Glebe, NSW 2037

Status: Recruiting

Check your eligibility here

Exploring the effect of combined THC and CBD (1:1) on tics in patients with Tourette syndrome. Eligible participants will undergo two 8-week treatment periods receiving either active or placebo treatment. This study is being led by Dr Philip Mosley. See here for more information.

Study site: The Wesley Hospital, Coronation Dr, Auchenflower, QLD 4066

Status: Recruiting

Check your eligibility here

The CAPS study

Exploring the effect of oral CBD on anxiety in youth who are unresponsive to standard treatments. Eligible participants undergo a 12-week open-label trial of CBD in addition to cognitive behavioural therapy. This study is being led by Professor Paul Amminger. See here for more information.

Study site: Headspace youth health clinic, Glenroy, VIC 3046

Status: No longer recruiting patients as of Sept 2019. 

Surveys

There are no currently active surveys.

Please check back regularly as we release new surveys several times per year.

See here for a list of past completed surveys.

Related articles